Unknown

Dataset Information

0

Arterial injury promotes medial chondrogenesis in Sm22 knockout mice.


ABSTRACT:

Aims

Expression of SM22 (also known as SM22alpha and transgelin), a vascular smooth muscle cells (VSMCs) marker, is down-regulated in arterial diseases involving medial osteochondrogenesis. We investigated the effect of SM22 deficiency in a mouse artery injury model to determine the role of SM22 in arterial chondrogenesis.

Methods and results

Sm22 knockout (Sm22(-/-)) mice developed prominent medial chondrogenesis 2 weeks after carotid denudation as evidenced by the enhanced expression of chondrogenic markers including type II collagen, aggrecan, osteopontin, bone morphogenetic protein 2, and SRY-box containing gene 9 (SOX9). This was concomitant with suppression of VSMC key transcription factor myocardin and of VSMC markers such as SM ?-actin and myosin heavy chain. The conversion tendency from myogenesis to chondrogenesis was also observed in primary Sm22(-/-) VSMCs and in a VSMC line after Sm22 knockdown: SM22 deficiency altered VSMC morphology with compromised stress fibre formation and increased actin dynamics. Meanwhile, the expression level of Sox9 mRNA was up-regulated while the mRNA levels of myocardin and VSMC markers were down-regulated, indicating a pro-chondrogenic transcriptional switch in SM22-deficient VSMCs. Furthermore, the increased expression of SOX9 was mediated by enhanced reactive oxygen species production and nuclear factor-?B pathway activation.

Conclusion

These findings suggest that disruption of SM22 alters the actin cytoskeleton and promotes chondrogenic conversion of VSMCs.

SUBMITTER: Shen J 

PROVIDER: S-EPMC3058734 | biostudies-literature | 2011 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Arterial injury promotes medial chondrogenesis in Sm22 knockout mice.

Shen Jianbin J   Yang Maozhou M   Jiang Hong H   Ju Donghong D   Zheng Jian-Pu JP   Xu Zhonghui Z   Liao Tang-Dong TD   Li Li L  

Cardiovascular research 20101222 1


<h4>Aims</h4>Expression of SM22 (also known as SM22alpha and transgelin), a vascular smooth muscle cells (VSMCs) marker, is down-regulated in arterial diseases involving medial osteochondrogenesis. We investigated the effect of SM22 deficiency in a mouse artery injury model to determine the role of SM22 in arterial chondrogenesis.<h4>Methods and results</h4>Sm22 knockout (Sm22(-/-)) mice developed prominent medial chondrogenesis 2 weeks after carotid denudation as evidenced by the enhanced expre  ...[more]

Similar Datasets

| S-EPMC6997457 | biostudies-literature
| S-EPMC2896867 | biostudies-literature
| S-EPMC6632006 | biostudies-literature
| S-EPMC6696997 | biostudies-literature
| S-EPMC7139303 | biostudies-literature
| S-EPMC3154990 | biostudies-literature
| S-EPMC3523707 | biostudies-literature
| S-EPMC5468173 | biostudies-literature
| S-EPMC5986784 | biostudies-literature
| S-EPMC6786310 | biostudies-literature